<DOC>
<DOCNO>EP-0612319</DOCNO> 
<TEXT>
<INVENTION-TITLE>
BENZOHETEROCYCLIC COMPOUNDS AS OXYTOCIN AND VASOPRESSIN ANTAGONISTS.
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D40100	C07D40106	C07D40114	C07D40500	C07D40506	C07D40900	C07D40906	C07D40914	C07D41300	C07D41314	C07D41700	C07D41706	C07D52100	C07D52100	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D401	C07D401	C07D401	C07D405	C07D405	C07D409	C07D409	C07D409	C07D413	C07D413	C07D417	C07D417	C07D521	C07D521	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Novel benzoheterocyclic compound of formula (1) and pharmaceutically acceptable salts thereof, which show excellent antivasopressin activity and oxytocin antagonistic activity, and are useful as a vasopressin antagonist or oxytocin antagonist. A is a 5- or 6-membered unsaturated heterocyclic residue having 1 to 2 heteroatoms. B1 and B2 are each methylene or a group of the formula: -NR8- (wherein R8 is a hydrogen atom or a lower alkyl group).
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
OTSUKA PHARMA CO LTD
</APPLICANT-NAME>
<APPLICANT-NAME>
OTSUKA PHARMACEUTICAL CO., LTD.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
KAN KEIZO
</INVENTOR-NAME>
<INVENTOR-NAME>
KONDO KAZUMI - NAKAKIRAI-AZA-I
</INVENTOR-NAME>
<INVENTOR-NAME>
OGAWA HIDENORI
</INVENTOR-NAME>
<INVENTOR-NAME>
TOMINAGA MICHIAKI - TAKAISO
</INVENTOR-NAME>
<INVENTOR-NAME>
YABUUCHI YOICHI - OMATSU KAWAU
</INVENTOR-NAME>
<INVENTOR-NAME>
YAMASHITA HIROSHI - SASAKINO-A
</INVENTOR-NAME>
<INVENTOR-NAME>
KAN, KEIZO
</INVENTOR-NAME>
<INVENTOR-NAME>
KONDO, KAZUMI 55-11, NAKAKIRAI-AZA-INAMOTO
</INVENTOR-NAME>
<INVENTOR-NAME>
OGAWA, HIDENORI
</INVENTOR-NAME>
<INVENTOR-NAME>
TOMINAGA, MICHIAKI 310-6, TAKAISO
</INVENTOR-NAME>
<INVENTOR-NAME>
YABUUCHI, YOICHI 900-25, OMATSU KAWAUCHI-CHO
</INVENTOR-NAME>
<INVENTOR-NAME>
YAMASHITA, HIROSHI 57-1, SASAKINO-AZA-HACHIKAMI
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
 D E S C R I P T I O NBenzoheterocyclic compounds as oxytocin and vasopressln antagonistsTechnical FieldThe invention relates to novel benzoheterocyclic compounds which are useful as medicines.Background ArtVarious benzoheterocyclic compounds analogous to the compounds of the present invention have been known to have anti-vasopressin activities in European Patent Publication 0382185 (published on August 15, 1990), WO 91/05549 (published on May 2, 1991 ), and WO 91/16916 (published on November 14, 1991). These known compounds are similar to the compounds of the present invention in the benzoheterocyclic nucleus of the chemical structure but are different from the compounds of the present invention in the substituent at 1 -position and in the anti-vasopressin activities to some extent.Disclosure of the InventionAn object of the present invention is to provide benzoheterocyclic compounds of the formula (1 ):
 wherein R1 is hydrogen atom or a halogen atom,R2 is hydrogen atom, oxo group, a lower alkylidene group, hydroxy group, a lower alkoxy group, a lower alkenyloxy group, a hydroxy-substituted lower alkoxy group, a lower alkoxycarbonyl-substituted lower alkoxy group, a 

carboxy-substituted lower alkoxy group, a lower alkylsulfonyloxy-substituted lower alkoxy group, a phthalimide-substituted lower alkoxy group, a hydroxy- substituted lower alkyl group, a group of the formula: -O-D-(CO)|NR4R5(wherein D is a lower alkylene group, I is 0 or 1 , R4 and R5 are the same or different and are hydrogen atom, a lower alkyl group, a lower alkanoyl group, a cycloalkyl group, or an amino-substituted lower alkyl group which may optionally have a lower alkyl substituent, or R4 and R5 may combine together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group which may be intervened or not with a nitrogen atom, an oxygen atom or a sulfur atom, wherein said heterocyclic group may optionally be substituted by a lower alkyl group or a lower alkanoyl group), a group of the formula: -E-(CO)|NR6R7 (wherein I is the same as defined above, E is a lower alkylene group, R6 and R7 are the same or different and are hydrogen atom, a lower alkyl group, an amino-substituted lower alkyl group which may optionally have a lower alkyl substituent, or a lower alkanoyl group, or R6 and R7 may combine together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group which may be intervened or not with a nitrogen atom, an oxygen atom or a sulfur atom, wherein
</DESCRIPTION>
<CLAIMS>
 CLAIMS
1. A benzoheterocyclic compound of the formula (1 ):

 A- R wherein R
1
 is hydrogen atom or a halogen atom,
R
2
 is hydrogen atom, oxo group, a lower alkyiidene group, hydroxy group, a lower alkoxy group, a lower alkenyloxy group, a hydroxy-substituted lower alkoxy group, a lower alkoxycarbonyl-substituted lower alkoxy group, a carboxy-substituted lower alkoxy group, a lower alkylsulfonyloxy-substituted lower alkoxy group, a phthalimide-substituted lower alkoxy group, a hydroxy- substituted lower alkyl group, a group of the formula: -0-D-(CO)|NR R
5
(wherein D is a lower alkylene group, I is 0 or 1 , R
4
 and R
5
 are the same or different and are hydrogen atom, a lower alkyl group, a lower alkanoyl group, a cycloalkyl group, or an amino-substituted lower alkyl group which may optionally have a lower alkyl substituent, or R
4
 and R
5
 may combine together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group which may be intervened or not with a nitrogen atom, an oxygen atom or a sulfur atom, wherein said heterocyclic group may optionally be substituted by a lower alkyl group or a lower alkanoyl group), a group of the formula: -E-(CO)|NR
6
R
7
 (wherein I is the same as defined above, E
is a lower alkylene group, R
6
 and R
7
 are the same or different and are hydrogen atom, a lower alkyl group, an amino-substituted lower alkyl group which may optionally have a lower alkyl substituent, or a lower alkanoyl group, 


or R
6
 and R
7
 may combine together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group which may be intervened or not with a nitrogen atom, an oxygen atom or a sulfur atom, wherein said heterocyclic group may optionally be substituted by a lower alkyl group, a lower alkanoyl group or a lower alkoxycarbonyl group), a lower alkanoyloxy-substituted lower alkyl group, a lower alkoxycarbonyl-substituted lower alkyl group, an amino which may optionally be substituted by a lower alkyl group or a cycloalkyl group, a carboxy-substituted lower alkyl group, a lower alkylsulfonyloxy-substituted lower alkyl group, a phthalimide-substituted lower alkyl group, an imidazolyl-substituted lower alkyl group, a 1 ,2,4-triazolyl- substituted lower alkyl group, an amino-substituted lower alkanoyloxy group which may optionally have a lower alkyl substituent, or an imidazolyl- substituted lower alkoxy group,
R
3
 is hydrogen atom, a lower alkoxy group or a hydroxy-substituted lower alkyl group,
B
1
 and B
2
 are each methylene group or a group of the formula: -NR
8
-
(wherein R
8
 is hydrogen atom or a lower alkyl group),
A is a 5- or 6-membered unsaturated heterocyclic residue having 1 to 2 heteroatoms selected from an oxygen atom, a nitrogen atom and a sulfur atom, and
R is a group of the formula: -NHR
A
 or a group of the formula:
wherein R
A
 is a group of the formula:

 [wherein m is an integer of 1 to 3, R
18
 is hydrogen atom, a lower alkyi group, a 


lower alkoxy group, a halogen atom, nitro group, a lower alkoxycarbonyl group, carboxy group, a lower alkoxycarbonyl-substituted lower alkoxy group, a hydroxy-substituted lower alkoxy group, a carboxy-substituted lower alkoxy group, a lower alkylsulfonyloxy-substituted lower alkoxy group, a phthalimide- substituted lower alkoxy group, or a group of the formula: -0-E-(CO)
|
NR
19
R
20
 (wherein E and I are the same as defined above, R
19
 and R
20
 are the same or different and are hydrogen atom or a lower alkyl group, or R
19
 and R
20
 may combine together with the nitrogen atom to which they bond to form a 5- or 6- membered saturated heterocyclic group which may be intervened or not with a nitrogen atom or an oxygen atom, wherein said heterocyclic group may optionally be substituted by a lower alkyl group, or an amino group which may optionally be substituted by a lower alkanoyl group)], thienylcarbonyl group, a cycloalkylcarbonyl group or a phenyl-lower alkanoyl group which may optionally have a lower alkyl substituent on the phenyl ring, or a salt thereof.
2. The benzoheterocyclic compound according to claim 1 , wherein both B
1
 and B
2
 are methylene group, the unsaturated heterocyclic residue for A is imidazolyl, pyrrolyl, imidazolinyl, pyridyl, pyrimidinyl, oxazolyl, pyrazolyl, pyrazolinyl, thiazolyl, thiazolinyl, thienyl, furyl, pyranyl, isothiazolyl, isoxazolyl, pyrazinyl, pyridazinyl, pyrrolinyl, or a salt thereof.
3. The benzoheterocyclic compound according to claim 1 , wherein one of B
1
 and B is methylene group and the other is a group of the formula:
-NR
8
- (wherein R
8
 is the same as defined above), and the unsaturated heterocyclic residue for A is imidazolyl, pyrrolyl, imidazolinyl, pyridyl, pyrimidinyl, oxazolyl, pyrazolyl, pyrazolinyl, thiazolyl, thiazolinyl, thienyl, furyl, pyranyl, isothiazolyl, isoxazolyl, pyrazinyl, pyridazinyl, pyrrolinyl, or a salt thereof.
4. The benzoheterocyclic compound according to claim 1 , wherein both B-
]
 and B
2
 are a group of the formula: -NR
8
- (wherein R
8
 is the same as 


defined above), and the unsaturated heterocyclic residue for A is imidazolyl, pyrrolyl, imidazolinyl, pyridyl, pyrimidinyl, oxazolyl, pyrazolyl, pyrazolinyl, thiazolyl, thiazolinyl, thienyl, furyl, pyranyl, isothiazolyl, isoxazolyl, pyrazinyl, pyridazinyl, pyrrolinyl, or a salt thereof. 5. The benzoheterocyclic compound according to claim 1 , wherein
R is a group of the formula:
and the unsaturated heterocyclic residue for A is imidazolyl, pyrrolyl, imidazolinyl, pyridyl, pyrimidinyl, oxazolyl, pyrazolyl, pyrazolinyl, thiazolyl, thiazolinyl, thienyl, furyl, pyranyl, isothiazolyl, isoxazolyl, pyrazinyl, pyridazinyl, pyrrolinyl, or a salt thereof. 6. The benzoheterocyclic compound according to ciaim 1 , wherein
R
3
 is a lower alkoxy group or a hydroxy-substituted lower alkyl group, or a salt thereof.
7. The benzoheterocyclic compound according to claim 2, wherein
A is pyridyl group, or a salt thereof. 8. The benzoheterocyclic compound according to claim 2, wherein
A is thiazolyl group, or a salt thereof.
9. The benzoheterocyclic compound according to claim 2, wherein
A is thienyl group or furyl group, and R is a group of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1), or a salt thereof. 10. The benzoheterocyclic compound according to claim 3, wherein
A is pyridyl group, and R is a group of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1 ), or a salt thereof.
11. The benzoheterocyclic compound according to claim 3, wherein
A is thiazolyl group, and R is a group of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1 ), or a salt thereof. 


 12. The benzoheterocyclic compound according to claim 3, wherein A is thienyl group or furyl group, and R is a group of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1), or a salt thereof.
13. The benzoheterocyclic compound according to claim 5, wherein A is pyridyl group, thiazolyl group, thienyl group or furyl group, and both B-| and
B
2
 are methylene group, or a salt thereof.
14. The benzoheterocyclic compound according to claim 7, wherein R
3
 is hydrogen atom, R is a group of the of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1 ), R
2
 is hydrogen atom, oxo group, a lower alkyiidene group, a lower alkoxy group, a lower alkenyloxy group, a hydroxy-substituted lower alkoxy group, a lower alkoxycarbonyl-substituted lower alkoxy group, a carboxy-substituted lower alkoxy group, a lower alkylsulfonyloxy-substituted lower alkoxy group, a phthalimide-substituted lower alkoxy group, a group of the formula: -O-D-(CO)|NR
4
R
5
 (wherein D is a lower alkylene group, I is 0 or 1 , R
4
 and R
5
 are the same or different and are hydrogen atom, a lower alkyl group, a lower alkanoyl group, a cycloalkyl group, or an amino-substituted lower alkyl group which may optionally have a lower alkyl substituent, or R
4
 and R
5
 may combine together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group which may be intervened or not with a nitrogen atom, an oxygen atom or a sulfur atom, wherein said heterocyclic group may optionally be substituted by a lower alkyl group or a lower alkanoyl group), a lower alkanoyloxy-substituted lower alkyl group, a lower alkoxycarbonyl-substituted lower alkyl group, an amino which may optionally be substituted by a lower alkyl group or a cycloalkyl group, a lower alkylsulfonyloxy-substituted lower alkyl group, a phthalimide-substituted lower alkyl group, an imidazolyl-substituted lower alkyl group, a 1 ,2,4-triazolyl- substituted lower alkyl group, an amino-substituted lower alkanoyloxy group which may optionally have a lower alkyl substituent, or an imidazolyl- substituted lower alkoxy group, or a salt thereof. 


 15. The benzoheterocyclic compound according to claim 7, wherein P.
3
 is hydrogen atom, R is a group of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1), R
2
 is a group of the formula: -E-(CO)
|
NR
6
R
7
 (wherein E and
I are the same as defined in claim 1 , R
6
 and R
7
 are the same or different and are hydrogen atom, a lower alkyl group, an amino-substituted lower alkyl group which may optionally have a lower alkyl substituent, or a lower alkanoyl group), or a salt thereof.
16. The benzoheterocyclic compound according to claim 7, wherein
R
3
 is hydrogen atom, R is a group of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1 ), R
2
 is a group of the formula: -E-(CO)|NR
6
R
7
 (wherein E and
I are the same as defined above, R
6
 and R
7
 combine together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group which may be intervened or not with a nitrogen atom, an oxygen atom or a sulfur atom, wherein said heterocyclic group is pyrrolidinyl, piperidinyl, piperazinyl, morpholino or thiomorphlino, and said heterocyclic group may optionally be substituted by a lower alkyl group, a lower alkanoyl group or a lower alkoxycarbonyl group), or a salt thereof.
17. The benzoheterocyclic compound according to claim 7, wherein R
3
 is hydrogen atom, R is a group of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1 ), R
2
 is hydroxy group, a carboxy-substituted lower alkyl group or a hydroxy-substituted lower alkyl group, or a salt thereof.
18. The benzoheterocyclic compound according to claim 8, wherein
R
3
 is hydrogen atom, R is a group of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1 ), R
2
 is hydrogen atom, oxo group, a lower alkyiidene group, a IOW Î“ alkoxy group, a lower alkenyloxy group, a hydroxy-substituted lower alkoxy group, a lower alkoxycarbonyl-substituted lower alkoxy group, a carboxy-substituted lower alkoxy group, a lower alkylsulfonyloxy-substituted lower alkoxy group, a phthalimide-substituted lower alkoxy group, a group of the formula: -O-D-(CO)|NR R
5
 (wherein D is a lower alkylene group, I is 0 or 1 , 


R
4
 and R
5
 are the same or different and are hydrogen atom, a lower alkyl group, a lower alkanoyl group, a cycloalkyl group, or an amino-substituted lower alkyl group which may optionally have a lower alkyl substituent, or R
4
 and R
5
 may combine together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group which may be intervened or not with a nitrogen atom, an oxygen atom or a sulfur atom, wherein said heterocyclic group may optionally be substituted by a lower alkyl group or a lower alkanoyl group), a lower alkanoyloxy-substituted lower alkyl group, a lower alkoxycarbonyl-substituted lower alkyl group, an amino which may optionally be substituted by a lower alkyl group or a cycloalkyl group, a lower alkylsulfonyloxy-substituted lower alkyl group, a phthalimide-substituted lower alkyl group, an imidazolyl-substituted lower alkyl group, a 1 ,2,4-triazolyl- substituted lower alkyl group, an amino-substituted lower alkanoyloxy group which may optionally have a lower alkyl substituent, or an imidazolyl- substituted lower alkoxy group, or a salt thereof.
19. The benzoheterocyclic compound according to claim 8, wherein
R
3
 is hydrogen atom, R is a group of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1 ), R
2
 is a group of the formula: -E-(CO)|NR
6
R
7
 (wherein E and
I are the same as defined in claim 1 , R
6
 and R
7
 are the same or different and are hydrogen atom, a lower alkyl group, an amino-substituted lower alkyl group which may optionally have a lower alkyl substituent, or a lower alkanoyl group), or a salt thereof.
20. The benzoheterocyclic compound according to claim 8, wherein R
3
 is hydrogen atom, R is a group of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1), R
2
 is a group of the formula: -E-(CO)|NR
6
R
7
 (wherein E and
I are the same as defined above, R
6
 and R
7
 combine together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group which may be intervened or not with a nitrogen atom, an oxygen atom or a sulfur atom, wherein said heterocyclic group is pyrrolidinyl, piperidinyl, 


piperazinyl, morpholino or thiomorphlino, and said heterocyclic group may optionally be substituted by a lower alkyl group, a lower alkanoyl group or a lower alkoxycarbonyl group), or a salt thereof.
21. The benzoheterocyclic cyclic compound according to claim 8, wherein R
3
 is hydrogen atom, R is a group of the formula: -NHR
A
 (R
A
 is the same as defined in claim 1 ), R
2
 is hydroxy group, a carboxy-substituted lower alkyl group or a hydroxy-substituted lower alkyl group, or a salt thereof.
22. The benzoheterocyclic compound according to any one of claims 14 to 21 , wherein R
A
 is a group of the formula:
(in which R
18
 is a lower alkyl group or a halogen atom, and m is 1), or a salt thereof. 23. The benzoheterocyclic compound according to any one of claims 14 to 21 , wherein R
A
 is a group of the formula:

 (in which R
18
 is hydrogen atom, a lower alkoxy group, nitro group, a lower alkoxycarbonyl group, carboxy group, a lower alkoxycarbonyl-substituted lower alkoxy group, a hydroxy-substituted lower alkoxy group, a carboxy-substituted lower alkoxy group, a lower alkylsulfonyloxy-substituted lower alkoxy group, a phthalimide-substituted lower alkoxy group, or a group of the formula: -O-E-(CO)|NR1
9
R
2
0 (E and I are the same as defined above, R
19
 and R
20
 are the same or different and are hydrogen atom or a lower alkyl group, or R
19
 and
R
20
 may combine together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group which may be intervened or not with a nitrogen atom or an oxygen atom, wherein said heterocyclic group may 


optionally be substituted by a lower alkyl group, or an amino group which may optionally be substituted by a lower alkanoyl group), and m is 1), or a salt thereof.
24. The benzoheterocyclic compound according to any one of claims 14 to 21 , wherein R
A
 is a group of the formula:
(in which R 
8
 is the same as defined in claim 1 , and m is 2 or 3), or a salt thereof.
25. The benzoheterocyclic compound according to any one of claims 14 to 21 , wherein R
A
 is thienylcarbonyl group, a cycloalkylcarbonyl group or a phenyl-lower alkanoyl group which may optionally have a lower alkyl substituent on the phenyl ring, or a salt thereof. 26. The benzoheterocyclic compound according to claim 1 , which is
7-chloro-5-[N-methyl-N-(2-diethylaminoethyl)amino]carbonylmethyl-1 -[6-(2- methylbenzoylamino)nicotinoyl]
-2,3,4,5-tetrahydro-1 H-benzazepine.
27. The benzoheterocyclic compound according to claim 1 , which is 7-chloro-5-carboxymethyl-1-[6-(2-bromobenzoylamino)nicotinoyl]-2, 3,4,5- tetrahydro-1 H-benzazepine.
28. The benzoheterocyclic compound according to claim 1 , which is 7-chloro-5-(2-hydroxyethyl)-1 -[6-(2-methylbenzoylamino)nicotinoyl]-2, 3,4,5- tetrahydro-1 H-benzazepine.
29. The benzoheterocyclic compound according to claim 1 , which is 7-chloro-5-(2-acetylaminoethyl)-1 -[6-(2-methylbenzoylamino)nicotinoyl]-
2, 3, 4, 5-tetrahydro-1 H-benzazepine.
30. The benzoheterocyclic compound according to claim 1 , which is 7-chloro-5-hydroxy-1 -[5-(2-methylbenzoylamino)-2-thiazolylcarbonyl]-2,3,4,5- tetrahydro-1 H-benzazepine. 31. An vasopressin antagonist, which comprises as an active 



ingredient a benzoheterocyclic compound as set forth in claim 1 , or a pharmaceutically acceptable salt thereof, in admixture with a pharmaceutically acceptable carrier or diluent.
32. An oxytocin antagonist, which comprises as an active ingredient a benzoheterocyclic compound as set forth in claim 1 , or a pharmaceutically acceptable salt thereof, in admixture with a pharmaceutically acceptable carrier or diluent.
33. A process for preparing a benzoheterocyclic compound of the formula (1):

 wherein R
1
 is hydrogen atom or a halogen atom,
R
2
 is hydrogen atom, oxo group, a lower alkyiidene group, hydroxy group, a lower alkoxy group, a lower alkenyloxy group, a hydroxy-substituted lower alkoxy group, a lower alkoxycarbonyl-substituted lower alkoxy group, a carboxy-substituted lower alkoxy group, a lower alkylsulfonyloxy-substituted lower alkoxy group, a phthalimide-substituted lower alkoxy group, a hydroxy- substituted lower alkyl group, a group of the formula: -0-D-(CO)
(
NR
4
R
5
(wherein D is a lower alkylene group, I is 0 or 1 , R
4
 and R
5
 are the same or different and are hydrogen atom, a lower alkyl group, a lower alkanoyl group, a cycloalkyl group, or an amino-substituted lower alkyl group which may optionally have a lower alkyl substituent, or R
4
 and R
5
 may combine together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group which may be intervened or not with a nitrogen atom, an oxygen atom or a sulfur atom, wherein said heterocyclic group may 



optionally be substituted by a lower alkyl group or a lower alkanoyl group), a group of the formula: -E-(CO)|NR
6
R
7
 (wherein I is the same as defined above, E is a lower alkylene group, R
6
 and R
7
 are the same or different and are hydrogen atom, a lower alkyl group, an amino-substituted lower alkyl group which may optionally have a lower alkyl substituent, or a lower alkanoyl group, or R
6
 and R
7
 may combine together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group which may be intervened or not with a nitrogen atom, an oxygen atom or a sulfur atom, wherein said heterocyclic group may optionally be substituted by a lower alkyl group, a lower alkanoyl group or a lower alkoxycarbonyl group), a lower alkanoyloxy-substituted lower alkyl group, a lower alkoxycarbonyl-substituted lower alkyl group, an amino which may optionally be substituted by a lower alkyl group or a cycloalkyl group, a carboxy-substituted lower alkyl group, a lower alkylsulfonyloxy-substituted lower alkyl group, a phthalimide-substituted lower alkyl group, an imidazolyl-substituted lower alkyl group, a 1 ,2,4-triazolyl- substituted lower alkyl group, an amino-substituted lower alkanoyloxy group which may optionally have a lower alkyl substituent, or an imidazolyl- substituted lower alkoxy group,
R
3
 is hydrogen atom, a lower alkoxy group or a hydroxy-substituted lower alkyl group,
B
1
 and B
2
 are each methylene group or a group of the formula: -NR
8
-
(wherein R
8
 is hydrogen atom or a lower alkyl group),
A is a 5- or 6-membered unsaturated heterocyclic residue having 1 to 2 heteroatoms selected from an oxygen atom, a nitrogen atom and a sulfur atom, and
R is a group of the formula: -NHR
A
 or a group of the formula: 

wherein R
A
 is a group of the formula:
[wherein m is an integer of 1 to 3, R
18
 is hydrogen atom, a lower alkyl group, a lower alkoxy group, a halogen atom, nitro group, a lower alkoxycarbonyl group, carboxy group, a lower alkoxycarbonyl-substituted lower alkoxy group, a hydroxy-substituted lower alkoxy group, a carboxy-substituted lower alkoxy group, a lower alkylsulfonyloxy-substituted lower alkoxy group, a phthalimide- substituted lower alkoxy group, or a group of the formula: -O-E-(CO)|NR
19
R
20
(wherein E and I are the same as defined above, R
19
 and R
20
 are the same or different and are hydrogen atom or a lower alkyl group, or R
19
 and R
20
 may combine together with the nitrogen atom to which they bond to form a 5- or 6- membered saturated heterocyclic group which may be intervened or not with a nitrogen atom or an oxygen atom, wherein said heterocyclic group may optionally be substituted by a lower alkyl group, or an amino group which may optionally be substituted by a lower alkanoyl group)], thienylcarbonyl group, a cycloalkylcarbonyl group or a phenyl-lower alkanoyl group which may optionally have a lower alkyl substituent on the phenyl ring, or a salt thereof, which comprises reacting a benzoheterocyclic compound of the formula (2):

wherein R
1
 , R
2
, R
3
, B-
|
 and B are the same as defined above, with a carboxylic acid of the formula (3):
O
HOC I' -A- R ( W3) wherein A and R are the as defined above, by a conventional amido bond producing reaction.
34. A process for preparing a benzoheterocyclic compound of the formula (1A):

 wherein R
1
 , R
2
, R
3
, B-j , B
2
, A and R^ are the same as defined above, or a salt thereof, which comprising reacting a compound of the formula (4):

 A- NH
2
 wherein R
1
 , R
2
, R
3
, B 
f
 B
2
 and A are the same as defined above, with a compound of the formula (5):
R
A
OH (5) wherein R
A
 is the same as defined above. 

</CLAIMS>
</TEXT>
</DOC>
